Adam Cohen was Promoted as Interim President, Senior Vice President and General Counsel at Oklahoma-Medical-Research-Foundation

Date of management change: June 13, 2021 

What Happened?

Oklahoma City, -based Oklahoma-Medical-Research-Foundation Promoted Adam Cohen as Interim President, Senior Vice President and General Counsel

 

About the Company

Established in 1946, OMRF is an independent, nonprofit biomedical research institute with more than 450 staff and over 50 labs studying cancer, heart disease, autoimmune disorders, and diseases of aging. Breakthroughs in our labs have led to three FDA-approved drugs, including the first targeted therapy approved in the U.S. for sickle cell disease and the first approved treatment for neuromyelitis optica spectrum disorder, a rare autoimmune disease. OMRF`s critical research is helping people live longer, healthier lives, one discovery at a time. Along the way, OMRF has garnered worldwide media attention, from leading scientific publications like The New England Journal of Medicine and Science to The New York Times and The Wall Street Journal. By pushing the boundaries of biomedical science, our researchers are helping to win the war against human disease, one discovery at a time.

 

About the Person

Adam Cohen is Interim President, Senior Vice President and General Counsel at Oklahoma Medical Research Foundation. Previously, Adam held various senior legal leadership roles in the industry.

 

Info Source

News

 
 

Other IT executives who recently changed jobs as well: Shinaman Aileen, Lynch Jack, Zambuto Emily, Washington Geovette, Woods Shannon, Hobbs Joseph, Bell Erica, Joseph Tamara, Willoughby Scott, Hastings Stewart, Heffernan Ashleigh

You can find the full directory of IT executives here.

How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.